Search results
Results from the WOW.Com Content Network
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]
Isatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma. [6] [4]The most common side effects include neutropenia (low levels of neutrophils, a type of white blood cell), infusion reactions, pneumonia (infection of the lungs), upper respiratory tract infection (such as nose and throat infections), diarrhoea and bronchitis ...
In the European Union, pomalidomide, in combination with bortezomib and dexamethasone, is indicated in the treatment of adults with multiple myeloma who have received at least one prior treatment regimen including lenalidomide; [8] and in combination with dexamethasone is indicated in the treatment of adults with relapsed and refractory multiple myeloma who have received at least two prior ...
If you're feeling uneasy about the future of Social Security right now, you're not alone. A whopping 87% of U.S. adults say they're concerned about the program, according to a 2024 poll from ...
Here’s how to get rid of chest congestion medically and naturally, according to experts.
The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.
"Ongoing vaccine safety surveillance is essential after vaccines receive emergency-use authorization and/or licensure and vaccines are administered in the general population."
1991 – A CDC study showed that one in five teen deaths is gun-related, and firearm death rates for male teens exceeded those for all natural causes of death. 1992 – The National Academy of Sciences reported on a dangerous new phenomenon: the emergence of new and virulent diseases that are resistant to antibiotics.